Yunnan Botanee Bio-Technology Group Co Ltd (300957) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Yunnan Botanee Bio-Technology Group Co Ltd (300957) has a cash flow conversion efficiency ratio of 0.020x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥125.55 Million ≈ $18.37 Million USD) by net assets (CN¥6.22 Billion ≈ $910.32 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Yunnan Botanee Bio-Technology Group Co Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Yunnan Botanee Bio-Technology Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Yunnan Botanee Bio-Technology Group Co L for a breakdown of total debt and financial obligations.
Yunnan Botanee Bio-Technology Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Yunnan Botanee Bio-Technology Group Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Orion Oyj A
HE:ORNAV
|
0.086x |
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
-0.121x |
|
Watsco Inc
NYSE:WSO-B
|
0.108x |
|
Hinge Health, Inc.
NYSE:HNGE
|
0.169x |
|
ZhongAn Online P & C Insurance Co. Ltd
F:1ZO
|
0.032x |
|
China Railway Hi-tech Industry Corp Ltd
SHG:600528
|
0.112x |
|
Zhongshan Public Utilities Group Co Ltd
SHE:000685
|
0.020x |
|
Gujarat Mineral Development Corporation Limited
NSE:GMDCLTD
|
0.038x |
Annual Cash Flow Conversion Efficiency for Yunnan Botanee Bio-Technology Group Co Ltd (2017–2024)
The table below shows the annual cash flow conversion efficiency of Yunnan Botanee Bio-Technology Group Co Ltd from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Yunnan Botanee Bio-Technology Group Co L.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥6.19 Billion ≈ $905.47 Million |
CN¥694.87 Million ≈ $101.68 Million |
0.112x | +10.67% |
| 2023-12-31 | CN¥6.02 Billion ≈ $880.30 Million |
CN¥610.44 Million ≈ $89.33 Million |
0.101x | -26.13% |
| 2022-12-31 | CN¥5.60 Billion ≈ $819.72 Million |
CN¥769.45 Million ≈ $112.59 Million |
0.137x | -43.06% |
| 2021-12-31 | CN¥4.78 Billion ≈ $699.24 Million |
CN¥1.15 Billion ≈ $168.68 Million |
0.241x | -32.74% |
| 2020-12-31 | CN¥1.20 Billion ≈ $175.86 Million |
CN¥431.03 Million ≈ $63.07 Million |
0.359x | -46.99% |
| 2019-12-31 | CN¥761.02 Million ≈ $111.36 Million |
CN¥514.92 Million ≈ $75.35 Million |
0.677x | +198.51% |
| 2018-12-31 | CN¥450.87 Million ≈ $65.98 Million |
CN¥102.20 Million ≈ $14.95 Million |
0.227x | -70.62% |
| 2017-12-31 | CN¥262.44 Million ≈ $38.40 Million |
CN¥202.44 Million ≈ $29.62 Million |
0.771x | -- |
About Yunnan Botanee Bio-Technology Group Co Ltd
Yunnan Botanee Bio-Technology Group Co.LTD, together with its subsidiaries, engages in the research, development, production, and sale of cosmetics in China and internationally. The company operates through Skin Care Products and Medical Instruments segments. It offers face creams, lotions, masks, and essences and lotions; and makeup products, including primers, powders, BB creams, and makeup rem… Read more